Exact Sciences Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Eleni, and I am on Tycho's life science team. It is my pleasure today to introduce our next company, Exact Sciences. We have CEO, Kevin Conroy, joining us today. As a reminder, you can submit questions through the Ask a Question feature on the event [debut] on the website, and we will get to them in the Q&A at the end of the presentation.
And with that, I'll hand it over to Kevin.
Thank you, and thanks to all of you for joining us and to JPMorgan for having us back. Against the backdrop of a challenging year caused by COVID-19, our team's execution puts us in a position to help even more patients now and in the future. This comes at a time when there's a new recognition and an appreciation for the power of cancer diagnostics. The focus is clearly shifting in oncology to earlier detection and smarter answers through tests that help guide
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |